Butterfly Q2 Margin Climbs to 63%
Butterfly Network (NYSE:BFLY), a medical device company known for its portable ultrasound technology, released its second quarter fiscal 2025 results on August 1, 2025. The headline news: it delivered a record gross margin of 63.7% (GAAP), narrowed its losses, and grew revenue by 9.0% compared to Q2 2024. However, revenue (GAAP) came in at $23.4 million, slightly shy of the $23.72 million projected by analysts. Non-GAAP earnings per share were $(0.03), better than the expected $(0.05) (adjusted). Management revised full-year revenue guidance lower, now projecting $91 million to $95 million for FY2025. versus its earlier target of approximately 20% year-on-year growth for FY2025. Overall, the quarter showed gains in operational efficiency and innovation, but slower revenue growth and a leadership change tempered the outlook.
Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q1 2025 earnings report.
Butterfly Network creates handheld ultrasound devices that use semiconductor chips instead of traditional stones, making their products more portable, affordable, and versatile for healthcare providers. Its core business revolves around the Ultrasound-on-Chip technology, aiming to make medical imaging more accessible in hospitals, clinics, and even home care settings. The company targets not only doctors and hospitals but also expands its reach to nurses, veterinarians, and global health organizations.
Source Fool.com
